Omni Bio Pharmaceutical, Inc. Share Price
Equities
OMBP
US68216L1008
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | +66.67% | +233.33% |
2016 | Omni Bio Pharmaceutical, Inc. cancelled the transaction announced on March 16, 2015 | CI |
2015 | Omni Bio Pharmaceutical, Inc. Announces Management Changes | CI |
Sales 2013 | - | Sales 2014 | - | Capitalization | 10.89M 909M |
---|---|---|---|---|---|
Net income 2013 | -7M -584M | Net income 2014 | -2M -167M | EV / Sales 2013 | - |
Net Debt 2013 | 441K 36.84M | Net Debt 2014 | 752K 62.79M | EV / Sales 2014 | - |
P/E ratio 2013 |
-1.5
x | P/E ratio 2014 |
-4.18
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+233.33% | 50.06K | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.41% | 22.28B | |
-11.90% | 22.41B | |
-5.99% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- OMBP Stock